Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 7/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24549553 | 0.77 | HSD11B1 (0.40) | NPC1RAB9AL3MBTL1ALDH1A1TDP1 | |
| SCHEMBL6897685 | 0.69 | HSD11B1 (0.38) | HSD11B1SIGMAR1 | |
| SCHEMBL24549652 | 0.68 | TDP1 (0.38) | RAB9AALDH1A1TDP1GPR35TSHR | |
| SCHEMBL23177230 | 0.67 | SLC6A2 (0.44) | ALDH1A1TDP1HSD11B1SIGMAR1MEN1 | |
| SCHEMBL24618124 | 0.65 | PDK2 (0.50) | NPC1RAB9AHSD11B1 | |
| SCHEMBL23628245 | 0.65 | HSD11B1 (0.40) | HSD11B1 | |
| SCHEMBL23319128 | 0.65 | PDK2 (0.44) | NPC1RAB9ATDP1HSD11B1KMT2A | |
| SCHEMBL25054783 | 0.65 | PDK2 (0.44) | NPC1RAB9ATDP1HSD11B1KMT2A | |
| SCHEMBL24728921 | 0.65 | ALDH1A1 (0.42) | L3MBTL1ALDH1A1TDP1HSD11B1MEN1 | |
| SCHEMBL24604948 | 0.65 | PDK2 (0.40) | ALDH1A1TDP1HSD11B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220199918-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220199918-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | EML4, SLC39A14, SLC39A7 | NPC1 1543/4885RAB9A 2924/4885L3MBTL1 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.